Related Experiment Video
Updated: May 18, 2026
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Efficacy of compound xuanju capsule on type-III prostatitis-related sexual dysfunction]
Xu-dong Li1, Hong-Lan Shao, Guan-Jie Song
1Department of Urology, Binzhou People's Hospital, Binzhou, Shandong 256600, China. wudilxd@sina.com
Objective:
To investigate the value of Compound Xuanju Capsule in the treatment of type-III prostatitis-related sexual dysfunction.
Methods:
We randomly divided 90 type-III prostatitis patients with sexual dysfunction diagnosed by NIH clinical criteria into an experiment group and a control group to be treated with Compound Xuanju Capsule and antibiotics, respectively. We analyzed the therapeutic results based on the scores on chronic prostatitis symptom index (CPSI), prostatitis-related sexual function index (PSFI ) and self-rating anxiety scale (SAS), and compared them between the two groups and with the baseline data.
Results:
The degree of prostatitis-related sexual dysfunction was not correlated with that of prostatitis symptoms. Prostatitis symptoms and sexual function were significantly improved in the experiment group than in the control (P < 0.05), and the SAS score was markedly lower in the former than in the latter (P < 0.05).
Conclusion:
Compound Xuanju Capsule can not only alleviate the symptoms of type-III prostatitis, but also improve its related sexual dysfunction and anxiety.
